Biotechnology Portfolio Biotechnology Fund Market Value

FBIOX Fund  USD 25.83  0.36  1.37%   
Biotechnology Portfolio's market value is the price at which a share of Biotechnology Portfolio trades on a public exchange. It measures the collective expectations of Biotechnology Portfolio Biotechnology investors about its performance. Biotechnology Portfolio is trading at 25.83 as of the 24th of January 2026; that is 1.37% down since the beginning of the trading day. The fund's open price was 26.19.
With this module, you can estimate the performance of a buy and hold strategy of Biotechnology Portfolio Biotechnology and determine expected loss or profit from investing in Biotechnology Portfolio over a given investment horizon. Check out Biotechnology Portfolio Correlation, Biotechnology Portfolio Volatility and Biotechnology Portfolio Alpha and Beta module to complement your research on Biotechnology Portfolio.
Symbol

Please note, there is a significant difference between Biotechnology Portfolio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotechnology Portfolio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotechnology Portfolio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biotechnology Portfolio 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biotechnology Portfolio's mutual fund what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biotechnology Portfolio.
0.00
10/26/2025
No Change 0.00  0.0 
In 3 months and 1 day
01/24/2026
0.00
If you would invest  0.00  in Biotechnology Portfolio on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding Biotechnology Portfolio Biotechnology or generate 0.0% return on investment in Biotechnology Portfolio over 90 days. Biotechnology Portfolio is related to or competes with Fidelity Freedom, Fidelity Puritan, Fidelity Puritan, Fidelity Freedom, Fidelity Freedom, Fidelity Salem, and Fidelity Flex. The fund invests primarily in common stocks More

Biotechnology Portfolio Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biotechnology Portfolio's mutual fund current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biotechnology Portfolio Biotechnology upside and downside potential and time the market with a certain degree of confidence.

Biotechnology Portfolio Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotechnology Portfolio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biotechnology Portfolio's standard deviation. In reality, there are many statistical measures that can use Biotechnology Portfolio historical prices to predict the future Biotechnology Portfolio's volatility.
Hype
Prediction
LowEstimatedHigh
24.4625.7727.08
Details
Intrinsic
Valuation
LowRealHigh
24.1625.4726.78
Details
Naive
Forecast
LowNextHigh
24.9326.2427.55
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
24.4525.2526.05
Details

Biotechnology Portfolio January 24, 2026 Technical Indicators

Biotechnology Portfolio Backtested Returns

At this stage we consider BIOTECHNOLOGY Mutual Fund to be very steady. Biotechnology Portfolio secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the fund had a 0.14 % return per unit of risk over the last 3 months. We have found twenty-six technical indicators for Biotechnology Portfolio Biotechnology, which you can use to evaluate the volatility of the entity. Please confirm Biotechnology Portfolio's Risk Adjusted Performance of 0.0922, downside deviation of 1.34, and Mean Deviation of 1.02 to double-check if the risk estimate we provide is consistent with the expected return of 0.18%. The fund shows a Beta (market volatility) of 0.44, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Biotechnology Portfolio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biotechnology Portfolio is expected to be smaller as well.

Auto-correlation

    
  -0.07  

Very weak reverse predictability

Biotechnology Portfolio Biotechnology has very weak reverse predictability. Overlapping area represents the amount of predictability between Biotechnology Portfolio time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biotechnology Portfolio price movement. The serial correlation of -0.07 indicates that barely 7.0% of current Biotechnology Portfolio price fluctuation can be explain by its past prices.
Correlation Coefficient-0.07
Spearman Rank Test-0.04
Residual Average0.0
Price Variance0.17

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in BIOTECHNOLOGY Mutual Fund

Biotechnology Portfolio financial ratios help investors to determine whether BIOTECHNOLOGY Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BIOTECHNOLOGY with respect to the benefits of owning Biotechnology Portfolio security.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation